CA2646421A1 - Vaccin vivant attenue contre la salmonella - Google Patents

Vaccin vivant attenue contre la salmonella Download PDF

Info

Publication number
CA2646421A1
CA2646421A1 CA002646421A CA2646421A CA2646421A1 CA 2646421 A1 CA2646421 A1 CA 2646421A1 CA 002646421 A CA002646421 A CA 002646421A CA 2646421 A CA2646421 A CA 2646421A CA 2646421 A1 CA2646421 A1 CA 2646421A1
Authority
CA
Canada
Prior art keywords
strain
mutant strain
mutant
vaccine
attenuated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002646421A
Other languages
English (en)
Inventor
Henri Marcel Jozef De Greve
Connie Theresia Adriaensen
Jean-Pierre Ernest Clement Hernalsteens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vrije Universiteit Brussel VUB
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2646421A1 publication Critical patent/CA2646421A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

L'invention porte sur des mutants à délétion guaB atténués d'une bactérie infectant les espèces vétérinaires, en particulier Salmonella enterica, sur leur utilisation et sur leur production. L'invention concerne également des vaccins vivants atténués fondés sur lesdits mutants, qui sont destinés à prévenir les infections bactériennes, en particulier la salmonellose, chez une espèce vétérinaire, en particulier la volaille.
CA002646421A 2006-03-20 2006-03-20 Vaccin vivant attenue contre la salmonella Abandoned CA2646421A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/BE2006/000019 WO2007106956A1 (fr) 2006-03-20 2006-03-20 Vaccin vivant atténué contre la salmonella

Publications (1)

Publication Number Publication Date
CA2646421A1 true CA2646421A1 (fr) 2007-10-11

Family

ID=37430822

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002646421A Abandoned CA2646421A1 (fr) 2006-03-20 2006-03-20 Vaccin vivant attenue contre la salmonella

Country Status (7)

Country Link
EP (1) EP2004802A1 (fr)
JP (1) JP2009529895A (fr)
AU (1) AU2006340699A1 (fr)
BR (1) BRPI0621489A2 (fr)
CA (1) CA2646421A1 (fr)
MX (1) MX2008012056A (fr)
WO (1) WO2007106956A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080260777A1 (en) 2007-04-19 2008-10-23 Sotomayor Konky Composition and method for controlling intestinal pathogenic organisms
US7935355B2 (en) 2007-04-19 2011-05-03 Nutritional Health Institute Laboratories, Llc Composition and method for controlling intestinal pathogenic organisms
WO2010083477A2 (fr) * 2009-01-16 2010-07-22 University Of Maryland, Baltimore Vaccin à large spectre contre les salmonelles non typhoïdiques
US9011871B2 (en) 2011-11-07 2015-04-21 University Of Maryland, Baltimore Broad spectrum vaccine against typhoidal and non-typhoidal Salmonella disease
CZ307672B6 (cs) * 2012-05-30 2019-02-13 VÝZKUMNÝ ÚSTAV VETERINÁRNÍHO LÉKAŘSTVÍ, v.v.i. Vakcína pro orální podání hospodářským zvířatům
CN119842745A (zh) * 2025-01-03 2025-04-18 扬州大学 鼠伤寒沙门菌毒力基因Ict的鉴定及其减毒疫苗候选株的制备与应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6190669B1 (en) * 1998-05-13 2001-02-20 University Of Maryland, Baltimore Attenuated mutants of salmonella which constitutively express the Vi antigen

Also Published As

Publication number Publication date
MX2008012056A (es) 2008-12-18
AU2006340699A1 (en) 2007-09-27
EP2004802A1 (fr) 2008-12-24
BRPI0621489A2 (pt) 2011-12-13
JP2009529895A (ja) 2009-08-27
WO2007106956A1 (fr) 2007-09-27

Similar Documents

Publication Publication Date Title
Salehi et al. Assessment of immunity against avian colibacillosis induced by an aroA mutant containing increased serum survival gene in broilers
CA2877817A1 (fr) Vaccins attenues contre le streptococcus suis et leurs procedes de fabrication et d'utilisation
US20110052635A1 (en) Live attenuated salmonella vaccine
Shahidi et al. The design and application of a bacterial ghost vaccine to evaluate immune response and defense against avian pathogenic Escherichia coli O2: K1 serotype
US20190322707A1 (en) Mutated Salmonella Enterica
EP2004802A1 (fr) Vaccin vivant atténué contre la salmonella
CN102676419B (zh) 一种伤寒沙门氏菌基因缺失菌株及由其制备的疫苗和应用
Zhao et al. Identification of a gene in Riemerella anatipestifer CH-1 (B739-2187) that contributes to resistance to polymyxin B and evaluation of its mutant as a live attenuated vaccine
ES2764173T3 (es) Bacterias modificadas para vacunas mejoradas contra la brucelosis
Barrow et al. Vaccination against Salmonella infections in food animals: rationale, theoretical basis and practical application.
Kremer et al. Evaluation of recombinant Salmonella expressing the flagellar protein fliC for persistence and enhanced antibody response in commercial turkeys
US20100260794A1 (en) Live attenuated salmonella vaccine
KR20080110594A (ko) 약독화 살모넬라 생백신
KR102007455B1 (ko) 방사선에 의한 약독화 생균 백신의 제조 방법 및 이로부터 제조된 약독화 생균 백신 조성물
KR20080105099A (ko) 약독화 살모넬라 생백신
KR101950931B1 (ko) ptsI 및 crr 유전자 결손된 약독화 살모넬라 타이피뮤리움 균주 및 상기 균주를 이용한 생균 백신 조성물
EP4686480A1 (fr) Vaccin vivant atténué contre e. coli
US11541109B2 (en) Method for preparing live attenuated vaccine by irradiation and live attenuated vaccine composition prepared by the same
KR101774863B1 (ko) 살모넬라증 치료를 위한 변이 균주 ｈｉｄ２０９２와 ｈｉｄ２１１４ 및 이를 포함하는 살모넬라증 약제학적 조성물
Pumtang-on Investigation of Campylobacter jejuni and Campylobacter coli colonisation of commercial free-range chickens
Van der Merwe Preliminary investigations into ostrich mycoplasmas: identification of vaccine candidate genes and immunity elicited by poultry mycoplasma vaccines
CN116836900A (zh) 肠炎沙门菌ryhB-1和sopE双基因缺失株及其作为减毒疫苗候选株的应用
Linde et al. Prophylaxis of Salmonella (S.) abortus ovis caused abortions of sheep by a S. typhimurium live vaccine
Lee Personal Profile
Kumar MOLECULAR CLONING, EXPRESSION AND In-silico CHARACTERIZATION OF IMMUNOGENIC Omp28 GENE OF Salmonella Typhimurium

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead

Effective date: 20130320